IL115276A - תולדות של a ,4 ,35, 3 טטראהידרואוקסאזולו )a-3,4( קוינולין- 1 - און המותמרות בעמודה 7 הכנתן ותכשירים פרמצבטיים המכילים אותן - Google Patents

תולדות של a ,4 ,35, 3 טטראהידרואוקסאזולו )a-3,4( קוינולין- 1 - און המותמרות בעמודה 7 הכנתן ותכשירים פרמצבטיים המכילים אותן

Info

Publication number
IL115276A
IL115276A IL11527695A IL11527695A IL115276A IL 115276 A IL115276 A IL 115276A IL 11527695 A IL11527695 A IL 11527695A IL 11527695 A IL11527695 A IL 11527695A IL 115276 A IL115276 A IL 115276A
Authority
IL
Israel
Prior art keywords
quinolin
oxazolo
tetrahydro
formula
derivative
Prior art date
Application number
IL11527695A
Other languages
English (en)
Other versions
IL115276A0 (en
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL115276A0 publication Critical patent/IL115276A0/xx
Publication of IL115276A publication Critical patent/IL115276A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Quinoline Compounds (AREA)
IL11527695A 1994-09-05 1995-09-12 תולדות של a ,4 ,35, 3 טטראהידרואוקסאזולו )a-3,4( קוינולין- 1 - און המותמרות בעמודה 7 הכנתן ותכשירים פרמצבטיים המכילים אותן IL115276A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9410600A FR2724171B1 (fr) 1994-09-05 1994-09-05 Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
IL115276A0 IL115276A0 (en) 1996-01-19
IL115276A true IL115276A (he) 1998-12-06

Family

ID=9466686

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11527695A IL115276A (he) 1994-09-05 1995-09-12 תולדות של a ,4 ,35, 3 טטראהידרואוקסאזולו )a-3,4( קוינולין- 1 - און המותמרות בעמודה 7 הכנתן ותכשירים פרמצבטיים המכילים אותן

Country Status (28)

Country Link
US (1) US5641785A (he)
EP (1) EP0699680B1 (he)
JP (1) JP4225585B2 (he)
KR (1) KR100392523B1 (he)
CN (1) CN1055472C (he)
AT (1) ATE190311T1 (he)
AU (1) AU687591B2 (he)
CA (1) CA2157427C (he)
CZ (1) CZ286128B6 (he)
DE (1) DE69515402T2 (he)
DK (1) DK0699680T3 (he)
ES (1) ES2145886T3 (he)
FI (1) FI110945B (he)
FR (1) FR2724171B1 (he)
GR (1) GR3033554T3 (he)
HK (1) HK1013652A1 (he)
HU (1) HU218587B (he)
IL (1) IL115276A (he)
NO (1) NO306617B1 (he)
NZ (1) NZ272920A (he)
PL (1) PL184412B1 (he)
PT (1) PT699680E (he)
RU (1) RU2141482C1 (he)
SI (1) SI0699680T1 (he)
SK (1) SK281867B6 (he)
TW (1) TW356467B (he)
UA (1) UA41916C2 (he)
ZA (1) ZA957414B (he)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
US7553967B2 (en) * 2004-03-12 2009-06-30 Wyeth 1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections
SG10201506994RA (en) * 2007-03-09 2015-10-29 Sanofi Aventis Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
RU2366430C2 (ru) 2007-05-23 2009-09-10 Виктор Иванович Рощин Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
CN105949120B (zh) * 2016-05-27 2018-07-24 广东工业大学 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624861B1 (fr) * 1987-12-21 1990-06-01 Delalande Sa Carbamates tricycliques, leur procede de preparation et leur application en therapeutique
ES2013391A6 (es) * 1989-02-08 1990-05-01 Consejo Superior Investigacion Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles.
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法

Also Published As

Publication number Publication date
KR960010648A (ko) 1996-04-20
CZ226295A3 (en) 1996-03-13
PL310273A1 (en) 1996-03-18
ZA957414B (en) 1996-04-15
DE69515402T2 (de) 2000-10-19
NO306617B1 (no) 1999-11-29
SK108995A3 (en) 1996-06-05
UA41916C2 (uk) 2001-10-15
US5641785A (en) 1997-06-24
SI0699680T1 (en) 2000-10-31
FR2724171B1 (fr) 1997-01-03
AU3041595A (en) 1996-03-21
DE69515402D1 (de) 2000-04-13
JPH0899881A (ja) 1996-04-16
NO953458D0 (no) 1995-09-04
IL115276A0 (en) 1996-01-19
HU9502578D0 (en) 1995-11-28
HK1013652A1 (en) 1999-09-03
FR2724171A1 (fr) 1996-03-08
TW356467B (en) 1999-04-21
ES2145886T3 (es) 2000-07-16
CN1055472C (zh) 2000-08-16
FI954141A0 (fi) 1995-09-04
HUT73435A (en) 1996-07-29
CZ286128B6 (cs) 2000-01-12
HU218587B (hu) 2000-10-28
DK0699680T3 (da) 2000-08-21
FI110945B (fi) 2003-04-30
KR100392523B1 (ko) 2003-11-12
ATE190311T1 (de) 2000-03-15
FI954141A (fi) 1996-03-06
RU2141482C1 (ru) 1999-11-20
SK281867B6 (sk) 2001-08-06
AU687591B2 (en) 1998-02-26
CA2157427C (en) 2010-06-01
JP4225585B2 (ja) 2009-02-18
GR3033554T3 (en) 2000-09-29
PT699680E (pt) 2000-08-31
NZ272920A (en) 1998-03-25
PL184412B1 (pl) 2002-10-31
CN1128763A (zh) 1996-08-14
EP0699680B1 (fr) 2000-03-08
EP0699680A1 (fr) 1996-03-06
CA2157427A1 (en) 1996-03-06
NO953458L (no) 1996-03-06

Similar Documents

Publication Publication Date Title
RU2544856C2 (ru) НОВЫЕ ПРОИЗВОДНЫЕ 2,3,4,5-ТЕТРАГИДРО-1-ПИРИДО[4,3-b]ИНДОЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
US11273168B2 (en) Methods of treating anxiety by administering a substituted quinolone
KR101369126B1 (ko) 탄소환 ｇｌｙｔ1 수용체 길항제
IL115276A (he) תולדות של a ,4 ,35, 3 טטראהידרואוקסאזולו )a-3,4( קוינולין- 1 - און המותמרות בעמודה 7 הכנתן ותכשירים פרמצבטיים המכילים אותן
KR20150007352A (ko) Kat ii 억제제로서 삼환 화합물
TW201348215A (zh) 雜環化合物
JP4565747B2 (ja) テトラヒドロイソキノリンアルカノール誘導体及びそれを含む薬学的組成物
US5955471A (en) Tetrahydroisoquinolinealkanol derivatives and pharmaceutical compositions containing same
WO2024035757A2 (en) Tryptamines and methods of treating mood disorders
KR20010108167A (ko) 테트라히드로이소퀴놀린알칸올 유도체 및 이를 함유하는약학적 조성물

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired